Evidence map›Paper›PMID 27111884›Full record

ArticleJournal of biophotonics2017

Colocalization of cellular nanostructure using confocal fluorescence and partial wave spectroscopy.

John E Chandler, Yolanda Stypula-Cyrus, Luay Almassalha, Greta Bauer, Leah Bowen, Hariharan Subramanian, Igal Szleifer, Vadim Backman

Abstract read
In one paragraph

Article in Journal of biophotonics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Label-free imaging of the native, living cellular nanoarchitecture using partial-wave spectroscopic microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

John E ChandlerBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Yolanda Stypula-CyrusBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Luay AlmassalhaBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Greta BauerBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Leah BowenBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Hariharan SubramanianBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Igal SzleiferBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Vadim BackmanBiomedical Engineering Department, Northwestern University, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Spatio-Temporal Organization of Chromatin and Information Transfer in CancerU54CA193419 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BACKMAN, VADIM · 2015 to 2020
$10.4M
Risk-stratification of Prostate Cancers via Field Carcinogenesis NanocytologyR01CA200064 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM, CRAWFORD, SUSAN E. · 2015 to 2019
$3.1M
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer ScreeningR01CA155284 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM, ROY, HEMANT K. · 2011 to 2014
$2.3M
High-throughput molecular-specific cell nanocytology for cancer screeningR01EB016983 · NIBIB · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM, SUBRAMANIAN, HARIHARAN · 2013 to 2016
$1.3M
NCI NIH HHS P30 CA060553NCI NIH HHS R01 CA155284NCI NIH HHS R01 CA200064NCI NIH HHS U54 CA193419NIBIB NIH HHS R01 EB016983NIGMS NIH HHS T32 GM008152
6 · The paper itself

Abstract

A new multimodal confocal microscope has been developed, which includes a parallel Partial Wave Spectroscopic (PWS) microscopy path. This combination of modalities allows molecular-specific sensing of nanoscale intracellular structure using fluorescent labels. Combining molecular specificity and sensitivity to nanoscale structure allows localization of nanostructural intracellular changes, which is critical for understanding the mechanisms of diseases such as cancer. To demonstrate the capabilities of this multimodal instrument, we imaged HeLa cells treated with valinomycin, a potassium ionophore that uncouples oxidative phosphorylation. Colocalization of fluorescence images of the nuclei (Hoechst 33342) and mitochondria (anti-mitochondria conjugated to Alexa Fluor 488) with PWS measurements allowed us to detect a significant decrease in nuclear nanoscale heterogeneity (Σ), while no significant change in Σ was observed at mitochondrial sites. In addition, application of the new multimodal imaging approach was demonstrated on human buccal samples prepared using a cancer screening protocol. These images demonstrate that nanoscale intracellular structure can be studied in healthy and diseased cells at molecular-specific sites.

Indexed as

Microscopy, ConfocalMicroscopy, FluorescenceSpectrum AnalysisCell NucleusCheekHeLa CellsHumansImage Processing, Computer-AssistedIonophoresMitochondriaMultimodal ImagingValinomycinIonophoresValinomycinchromatinconfocal microscopyhyperspectral microscopymitochondriananocytology

Identifiers

PMID27111884
PMCPMC5112146
OpenAlexW2345264759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.